カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のニコチン作動薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Nicotinic Agonists Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19459）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19459
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のニコチン作動薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ニコチン作動薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニコチン作動薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニコチン作動薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ニコチン、アセチルコリン、カルバコール、エピバチジン、その他

用途別セグメントは次のように区分されます。
・アルツハイマー病（AD）、統合失調症、その他

世界のニコチン作動薬市場の主要な市場プレーヤーは以下のとおりです。
・FORUM Pharmaceuticals、Karuna Pharmaceuticals、Sumitomo Dainippon Pharma Co、BMS、Oyster Point Pharma、Jiangsu Hansoh Pharmaceutical、Dalian Meilun Biotech Co

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニコチン作動薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニコチン作動薬メーカーの企業概要、2019年～2022年までのニコチン作動薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニコチン作動薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニコチン作動薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニコチン作動薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニコチン作動薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニコチン作動薬の産業チェーンを掲載しています。
・第13、14、15章では、ニコチン作動薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ニコチン作動薬の概要
- 種類別分析（2017年vs2021年vs2028年）：ニコチン、アセチルコリン、カルバコール、エピバチジン、その他
- 用途別分析（2017年vs2021年vs2028年）：アルツハイマー病（AD）、統合失調症、その他
- 世界のニコチン作動薬市場規模・予測
- 世界のニコチン作動薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- FORUM Pharmaceuticals、Karuna Pharmaceuticals、Sumitomo Dainippon Pharma Co、BMS、Oyster Point Pharma、Jiangsu Hansoh Pharmaceutical、Dalian Meilun Biotech Co
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ニコチン、アセチルコリン、カルバコール、エピバチジン、その他
・用途別分析2017年-2028年：アルツハイマー病（AD）、統合失調症、その他
・ニコチン作動薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ニコチン作動薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ニコチン作動薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ニコチン作動薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ニコチン作動薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nicotinic Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nicotinic Agonists market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Alzheimer’s Disease (AD) accounting for % of the Nicotinic Agonists global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nicotine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nicotinic Agonists include FORUM Pharmaceuticals, Karuna Pharmaceuticals, Sumitomo Dainippon Pharma Co, BMS, and Oyster Point Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nicotinic Agonists market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nicotine
Acetylcholine
Carbachol
Epibatidine
Others
Market segment by Application can be divided into
Alzheimer’s Disease (AD)
Schizophrenia
Others
The key market players for global Nicotinic Agonists market are listed below:
FORUM Pharmaceuticals
Karuna Pharmaceuticals
Sumitomo Dainippon Pharma Co
BMS
Oyster Point Pharma
Jiangsu Hansoh Pharmaceutical
Dalian Meilun Biotech Co
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinic Agonists product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicotinic Agonists, with price, sales, revenue and global market share of Nicotinic Agonists from 2019 to 2022.
Chapter 3, the Nicotinic Agonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinic Agonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nicotinic Agonists market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nicotinic Agonists.
Chapter 13, 14, and 15, to describe Nicotinic Agonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Nicotinic Agonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nicotinic Agonists Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Nicotine
1.2.3 Acetylcholine
1.2.4 Carbachol
1.2.5 Epibatidine
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nicotinic Agonists Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Alzheimer’s Disease (AD)
1.3.3 Schizophrenia
1.3.4 Others
1.4 Global Nicotinic Agonists Market Size & Forecast
1.4.1 Global Nicotinic Agonists Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nicotinic Agonists Sales in Volume (2017-2028)
1.4.3 Global Nicotinic Agonists Price (2017-2028)
1.5 Global Nicotinic Agonists Production Capacity Analysis
1.5.1 Global Nicotinic Agonists Total Production Capacity (2017-2028)
1.5.2 Global Nicotinic Agonists Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nicotinic Agonists Market Drivers
1.6.2 Nicotinic Agonists Market Restraints
1.6.3 Nicotinic Agonists Trends Analysis
2 Manufacturers Profiles
2.1 FORUM Pharmaceuticals
2.1.1 FORUM Pharmaceuticals Details
2.1.2 FORUM Pharmaceuticals Major Business
2.1.3 FORUM Pharmaceuticals Nicotinic Agonists Product and Services
2.1.4 FORUM Pharmaceuticals Nicotinic Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Karuna Pharmaceuticals
2.2.1 Karuna Pharmaceuticals Details
2.2.2 Karuna Pharmaceuticals Major Business
2.2.3 Karuna Pharmaceuticals Nicotinic Agonists Product and Services
2.2.4 Karuna Pharmaceuticals Nicotinic Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sumitomo Dainippon Pharma Co
2.3.1 Sumitomo Dainippon Pharma Co Details
2.3.2 Sumitomo Dainippon Pharma Co Major Business
2.3.3 Sumitomo Dainippon Pharma Co Nicotinic Agonists Product and Services
2.3.4 Sumitomo Dainippon Pharma Co Nicotinic Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BMS
2.4.1 BMS Details
2.4.2 BMS Major Business
2.4.3 BMS Nicotinic Agonists Product and Services
2.4.4 BMS Nicotinic Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Oyster Point Pharma
2.5.1 Oyster Point Pharma Details
2.5.2 Oyster Point Pharma Major Business
2.5.3 Oyster Point Pharma Nicotinic Agonists Product and Services
2.5.4 Oyster Point Pharma Nicotinic Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jiangsu Hansoh Pharmaceutical
2.6.1 Jiangsu Hansoh Pharmaceutical Details
2.6.2 Jiangsu Hansoh Pharmaceutical Major Business
2.6.3 Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Product and Services
2.6.4 Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Dalian Meilun Biotech Co
2.7.1 Dalian Meilun Biotech Co Details
2.7.2 Dalian Meilun Biotech Co Major Business
2.7.3 Dalian Meilun Biotech Co Nicotinic Agonists Product and Services
2.7.4 Dalian Meilun Biotech Co Nicotinic Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nicotinic Agonists Breakdown Data by Manufacturer
3.1 Global Nicotinic Agonists Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nicotinic Agonists Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nicotinic Agonists
3.4 Market Concentration Rate
3.4.1 Top 3 Nicotinic Agonists Manufacturer Market Share in 2021
3.4.2 Top 6 Nicotinic Agonists Manufacturer Market Share in 2021
3.5 Global Nicotinic Agonists Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nicotinic Agonists Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nicotinic Agonists Market Size by Region
4.1.1 Global Nicotinic Agonists Sales in Volume by Region (2017-2028)
4.1.2 Global Nicotinic Agonists Revenue by Region (2017-2028)
4.2 North America Nicotinic Agonists Revenue (2017-2028)
4.3 Europe Nicotinic Agonists Revenue (2017-2028)
4.4 Asia-Pacific Nicotinic Agonists Revenue (2017-2028)
4.5 South America Nicotinic Agonists Revenue (2017-2028)
4.6 Middle East and Africa Nicotinic Agonists Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nicotinic Agonists Sales in Volume by Type (2017-2028)
5.2 Global Nicotinic Agonists Revenue by Type (2017-2028)
5.3 Global Nicotinic Agonists Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nicotinic Agonists Sales in Volume by Application (2017-2028)
6.2 Global Nicotinic Agonists Revenue by Application (2017-2028)
6.3 Global Nicotinic Agonists Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nicotinic Agonists Sales by Type (2017-2028)
7.2 North America Nicotinic Agonists Sales by Application (2017-2028)
7.3 North America Nicotinic Agonists Market Size by Country
7.3.1 North America Nicotinic Agonists Sales in Volume by Country (2017-2028)
7.3.2 North America Nicotinic Agonists Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nicotinic Agonists Sales by Type (2017-2028)
8.2 Europe Nicotinic Agonists Sales by Application (2017-2028)
8.3 Europe Nicotinic Agonists Market Size by Country
8.3.1 Europe Nicotinic Agonists Sales in Volume by Country (2017-2028)
8.3.2 Europe Nicotinic Agonists Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nicotinic Agonists Sales by Type (2017-2028)
9.2 Asia-Pacific Nicotinic Agonists Sales by Application (2017-2028)
9.3 Asia-Pacific Nicotinic Agonists Market Size by Region
9.3.1 Asia-Pacific Nicotinic Agonists Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nicotinic Agonists Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nicotinic Agonists Sales by Type (2017-2028)
10.2 South America Nicotinic Agonists Sales by Application (2017-2028)
10.3 South America Nicotinic Agonists Market Size by Country
10.3.1 South America Nicotinic Agonists Sales in Volume by Country (2017-2028)
10.3.2 South America Nicotinic Agonists Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nicotinic Agonists Sales by Type (2017-2028)
11.2 Middle East & Africa Nicotinic Agonists Sales by Application (2017-2028)
11.3 Middle East & Africa Nicotinic Agonists Market Size by Country
11.3.1 Middle East & Africa Nicotinic Agonists Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nicotinic Agonists Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nicotinic Agonists and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nicotinic Agonists
12.3 Nicotinic Agonists Production Process
12.4 Nicotinic Agonists Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nicotinic Agonists Typical Distributors
13.3 Nicotinic Agonists Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nicotinic Agonists Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nicotinic Agonists Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. FORUM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. FORUM Pharmaceuticals Major Business
Table 5. FORUM Pharmaceuticals Nicotinic Agonists Product and Services
Table 6. FORUM Pharmaceuticals Nicotinic Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Karuna Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Karuna Pharmaceuticals Major Business
Table 9. Karuna Pharmaceuticals Nicotinic Agonists Product and Services
Table 10. Karuna Pharmaceuticals Nicotinic Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sumitomo Dainippon Pharma Co Basic Information, Manufacturing Base and Competitors
Table 12. Sumitomo Dainippon Pharma Co Major Business
Table 13. Sumitomo Dainippon Pharma Co Nicotinic Agonists Product and Services
Table 14. Sumitomo Dainippon Pharma Co Nicotinic Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BMS Basic Information, Manufacturing Base and Competitors
Table 16. BMS Major Business
Table 17. BMS Nicotinic Agonists Product and Services
Table 18. BMS Nicotinic Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Oyster Point Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Oyster Point Pharma Major Business
Table 21. Oyster Point Pharma Nicotinic Agonists Product and Services
Table 22. Oyster Point Pharma Nicotinic Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu Hansoh Pharmaceutical Major Business
Table 25. Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Product and Services
Table 26. Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Dalian Meilun Biotech Co Basic Information, Manufacturing Base and Competitors
Table 28. Dalian Meilun Biotech Co Major Business
Table 29. Dalian Meilun Biotech Co Nicotinic Agonists Product and Services
Table 30. Dalian Meilun Biotech Co Nicotinic Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Nicotinic Agonists Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Nicotinic Agonists Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Nicotinic Agonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Nicotinic Agonists Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Nicotinic Agonists Production Site of Key Manufacturer
Table 36. Nicotinic Agonists New Entrant and Capacity Expansion Plans
Table 37. Nicotinic Agonists Mergers & Acquisitions in the Past Five Years
Table 38. Global Nicotinic Agonists Sales by Region (2017-2022) & (K Units)
Table 39. Global Nicotinic Agonists Sales by Region (2023-2028) & (K Units)
Table 40. Global Nicotinic Agonists Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Nicotinic Agonists Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Nicotinic Agonists Sales by Type (2017-2022) & (K Units)
Table 43. Global Nicotinic Agonists Sales by Type (2023-2028) & (K Units)
Table 44. Global Nicotinic Agonists Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Nicotinic Agonists Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Nicotinic Agonists Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Nicotinic Agonists Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Nicotinic Agonists Sales by Application (2017-2022) & (K Units)
Table 49. Global Nicotinic Agonists Sales by Application (2023-2028) & (K Units)
Table 50. Global Nicotinic Agonists Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Nicotinic Agonists Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Nicotinic Agonists Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Nicotinic Agonists Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Nicotinic Agonists Sales by Country (2017-2022) & (K Units)
Table 55. North America Nicotinic Agonists Sales by Country (2023-2028) & (K Units)
Table 56. North America Nicotinic Agonists Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Nicotinic Agonists Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Nicotinic Agonists Sales by Type (2017-2022) & (K Units)
Table 59. North America Nicotinic Agonists Sales by Type (2023-2028) & (K Units)
Table 60. North America Nicotinic Agonists Sales by Application (2017-2022) & (K Units)
Table 61. North America Nicotinic Agonists Sales by Application (2023-2028) & (K Units)
Table 62. Europe Nicotinic Agonists Sales by Country (2017-2022) & (K Units)
Table 63. Europe Nicotinic Agonists Sales by Country (2023-2028) & (K Units)
Table 64. Europe Nicotinic Agonists Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Nicotinic Agonists Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Nicotinic Agonists Sales by Type (2017-2022) & (K Units)
Table 67. Europe Nicotinic Agonists Sales by Type (2023-2028) & (K Units)
Table 68. Europe Nicotinic Agonists Sales by Application (2017-2022) & (K Units)
Table 69. Europe Nicotinic Agonists Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Nicotinic Agonists Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Nicotinic Agonists Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Nicotinic Agonists Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Nicotinic Agonists Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Nicotinic Agonists Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Nicotinic Agonists Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Nicotinic Agonists Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Nicotinic Agonists Sales by Application (2023-2028) & (K Units)
Table 78. South America Nicotinic Agonists Sales by Country (2017-2022) & (K Units)
Table 79. South America Nicotinic Agonists Sales by Country (2023-2028) & (K Units)
Table 80. South America Nicotinic Agonists Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Nicotinic Agonists Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Nicotinic Agonists Sales by Type (2017-2022) & (K Units)
Table 83. South America Nicotinic Agonists Sales by Type (2023-2028) & (K Units)
Table 84. South America Nicotinic Agonists Sales by Application (2017-2022) & (K Units)
Table 85. South America Nicotinic Agonists Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Nicotinic Agonists Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Nicotinic Agonists Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Nicotinic Agonists Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Nicotinic Agonists Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Nicotinic Agonists Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Nicotinic Agonists Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Nicotinic Agonists Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Nicotinic Agonists Sales by Application (2023-2028) & (K Units)
Table 94. Nicotinic Agonists Raw Material
Table 95. Key Manufacturers of Nicotinic Agonists Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Nicotinic Agonists Typical Distributors
Table 99. Nicotinic Agonists Typical Customers
List of Figures
Figure 1. Nicotinic Agonists Picture
Figure 2. Global Nicotinic Agonists Revenue Market Share by Type in 2021
Figure 3. Nicotine
Figure 4. Acetylcholine
Figure 5. Carbachol
Figure 6. Epibatidine
Figure 7. Others
Figure 8. Global Nicotinic Agonists Revenue Market Share by Application in 2021
Figure 9. Alzheimer's Disease (AD)
Figure 10. Schizophrenia
Figure 11. Others
Figure 12. Global Nicotinic Agonists Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Nicotinic Agonists Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Nicotinic Agonists Sales (2017-2028) & (K Units)
Figure 15. Global Nicotinic Agonists Price (2017-2028) & (USD/Unit)
Figure 16. Global Nicotinic Agonists Production Capacity (2017-2028) & (K Units)
Figure 17. Global Nicotinic Agonists Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Nicotinic Agonists Market Drivers
Figure 19. Nicotinic Agonists Market Restraints
Figure 20. Nicotinic Agonists Market Trends
Figure 21. Global Nicotinic Agonists Sales Market Share by Manufacturer in 2021
Figure 22. Global Nicotinic Agonists Revenue Market Share by Manufacturer in 2021
Figure 23. Nicotinic Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Nicotinic Agonists Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Nicotinic Agonists Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Nicotinic Agonists Sales Market Share by Region (2017-2028)
Figure 27. Global Nicotinic Agonists Revenue Market Share by Region (2017-2028)
Figure 28. North America Nicotinic Agonists Revenue (2017-2028) & (USD Million)
Figure 29. Europe Nicotinic Agonists Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Nicotinic Agonists Revenue (2017-2028) & (USD Million)
Figure 31. South America Nicotinic Agonists Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Nicotinic Agonists Revenue (2017-2028) & (USD Million)
Figure 33. Global Nicotinic Agonists Sales Market Share by Type (2017-2028)
Figure 34. Global Nicotinic Agonists Revenue Market Share by Type (2017-2028)
Figure 35. Global Nicotinic Agonists Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Nicotinic Agonists Sales Market Share by Application (2017-2028)
Figure 37. Global Nicotinic Agonists Revenue Market Share by Application (2017-2028)
Figure 38. Global Nicotinic Agonists Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Nicotinic Agonists Sales Market Share by Type (2017-2028)
Figure 40. North America Nicotinic Agonists Sales Market Share by Application (2017-2028)
Figure 41. North America Nicotinic Agonists Sales Market Share by Country (2017-2028)
Figure 42. North America Nicotinic Agonists Revenue Market Share by Country (2017-2028)
Figure 43. United States Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Nicotinic Agonists Sales Market Share by Type (2017-2028)
Figure 47. Europe Nicotinic Agonists Sales Market Share by Application (2017-2028)
Figure 48. Europe Nicotinic Agonists Sales Market Share by Country (2017-2028)
Figure 49. Europe Nicotinic Agonists Revenue Market Share by Country (2017-2028)
Figure 50. Germany Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Nicotinic Agonists Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Nicotinic Agonists Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Nicotinic Agonists Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Nicotinic Agonists Revenue Market Share by Region (2017-2028)
Figure 59. China Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Nicotinic Agonists Sales Market Share by Type (2017-2028)
Figure 66. South America Nicotinic Agonists Sales Market Share by Application (2017-2028)
Figure 67. South America Nicotinic Agonists Sales Market Share by Country (2017-2028)
Figure 68. South America Nicotinic Agonists Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Nicotinic Agonists Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Nicotinic Agonists Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Nicotinic Agonists Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Nicotinic Agonists Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Nicotinic Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Nicotinic Agonists in 2021
Figure 80. Manufacturing Process Analysis of Nicotinic Agonists
Figure 81. Nicotinic Agonists Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • THR-βアゴニストのグローバル市場展望 2023年-2029年：仕様10mg以下、仕様10-50mg、仕様50mg以上
  • 世界のドーパミン作動薬市場2022年：市場規模予測（～2028年）
  • 世界の抗糖尿病グルカゴン様ペプチド1アゴニスト市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用容器閉鎖装置（CCS）市場2022年：市場規模予測（～2028年）
  • 世界のワクチン及び医薬品用ガラス瓶＆バイアル市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19459 )"世界のニコチン作動薬市場2022年：市場規模予測（～2028年）" (英文：Global Nicotinic Agonists Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。